{
    "2021-10-08": [
        [
            {
                "time": "",
                "original_text": "智飞生物跌8.08% 招商证券平安证券八月底唱多",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "招商证券",
                        "平安证券",
                        "唱多"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物收跌8.08%，现报146.14元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "收跌",
                        "股价"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股疫苗股补跌：智飞生物(300122.SZ)一度跌超9%",
                "features": {
                    "keywords": [
                        "A股",
                        "疫苗股",
                        "智飞生物",
                        "补跌"
                    ],
                    "sentiment_score": -0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "美国加大新冠检测，什么信号？境外疫苗有效率大降",
                "features": {
                    "keywords": [
                        "美国",
                        "新冠检测",
                        "疫苗有效率",
                        "境外"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "国际医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "21健讯Daily｜智飞生物新冠疫苗在印尼获批；厦门中高风险地区清零",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "印尼获批",
                        "厦门",
                        "中高风险地区清零"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "国际医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：国庆期间海外抗疫板块出现波动 建议理性看待新冠口服药影响",
                "features": {
                    "keywords": [
                        "医药行业",
                        "国庆",
                        "海外抗疫",
                        "新冠口服药"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "国际医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}